Three chemical pathways were used for the synthesis of four new N'-(2-chloroethyl)-N-[2-(methylsulfinyl)ethyl]- and N'-(2-chloroethyl)-N-[2-(methylsulfonyl)ethyl]-N- or N'-nitrosoureas. These compounds are plasma metabolites of CNCC, a promising antineoplastic (2-chloroethyl)nitrosourea. Preliminary antitumor evaluation was performed against L1210 leukemia implanted intraperitoneally in mice. Among these compounds, two of them exhibited a greater antitumor activity compared to that of the parent mixture.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/jm00147a040 | DOI Listing |
Publication Analysis
Top Keywords
preliminary antitumor
8
cysteamine 2-chloroethylnitrosoureas
4
2-chloroethylnitrosoureas synthesis
4
synthesis preliminary
4
antitumor three
4
three chemical
4
chemical pathways
4
pathways synthesis
4
synthesis n'-2-chloroethyl-n-[2-methylsulfinylethyl]-
4
n'-2-chloroethyl-n-[2-methylsulfinylethyl]- n'-2-chloroethyl-n-[2-methylsulfonylethyl]-n-
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!